Additionally, a specific CD14+ERO1A+ TAM cluster with detrimental prognostic value in human primary GBM has been identified, which showed a gene signature enriched in hypoxia-response, invasion and extracellular matrix organization. The gene discussed is CD14; the disease is glioblastoma.